Co-morbidity is the main cost driver among COPD-subjects

S. A. Jansson, H. Backman, E. Rönmark, B. Lundbäck, A. Lindberg (Luleå, Umeå, Gothenburg, Sweden)

Source: International Congress 2014 – Highlights in respiratory epidemiology
Session: Highlights in respiratory epidemiology
Session type: Oral Presentation
Number: 4439
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. A. Jansson, H. Backman, E. Rönmark, B. Lundbäck, A. Lindberg (Luleå, Umeå, Gothenburg, Sweden). Co-morbidity is the main cost driver among COPD-subjects. Eur Respir J 2014; 44: Suppl. 58, 4439

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comorbidity in patients with IHD - the prevalence of COPD
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016

Co-morbidities of COPD in primary care
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015

Comorbidities and COPD severity: The French Palomb cohort
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Comorbidities, gender-differences and COPD severity: The French Palomb cohort
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Comorbidities and burden of COPD: A population based case-control study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013


Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


Comorbidity at COPD - is actual problem of pulmonology
Source: International Congress 2014 – Predictors
Year: 2014


Comorbidity in patients with COPD in Russia
Source: Annual Congress 2013 –COPD treatment
Year: 2013


COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014


Use of medicines and prevalence of co-morbid diseases in subjects with and without COPD in Sweden
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013

Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Comorbidity level in asthma patients
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013

Gender difference in asthma; symptoms, risk factors, comorbidities and emergency visits
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015

COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014


Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


Comorbidity and some issues of cardiovascular disorders in disabled asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015